U.S. markets open in 2 hours 37 minutes

bioMérieux S.A. (BIM.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
119.80+0.80 (+0.67%)
As of 12:35PM CET. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close119.00
Open118.70
Bid0.00 x 0
Ask0.00 x 0
Day's Range118.40 - 120.40
52 Week Range75.00 - 144.80
Volume17,900
Avg. Volume131,265
Market Cap16.051B
Beta (5Y Monthly)-0.08
PE Ratio (TTM)46.51
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.19 (0.16%)
Ex-Dividend DateJul 14, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      French labs show how global supply bottlenecks thwart effort to ramp up testing

      Pierre-Adrien Bihl, who runs four labs that together conduct 800 tests a day in eastern France, has one explanation for what has gone wrong: a global supply chain that can't keep up. Clement ordered a new diagnostic machine from a South Korean manufacturer two months ago, which finally arrived last Friday, and now he says he can perform all tests in-house and deliver results in a day.

    • What Makes BIOMERIEUX (BMXMF) a New Buy Stock
      Zacks

      What Makes BIOMERIEUX (BMXMF) a New Buy Stock

      BIOMERIEUX (BMXMF) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    • What Makes BIOMERIEUX (BMXMF) a New Strong Buy Stock
      Zacks

      What Makes BIOMERIEUX (BMXMF) a New Strong Buy Stock

      BIOMERIEUX (BMXMF) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.